Jizhou Tan

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0003-4285-9510

发表论文 21 篇 · 总被引 1028 次 · h-index 13

代表论文

• TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma (2023 · Journal of Hepatology · 被引 224)
• Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy (2020 · Nucleic Acids Research · 被引 172)
• High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39 + CD8 + T cells (2020 · Gut · 被引 161)
• The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity (2021 · Molecular Therapy · 被引 127)
• Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients (2023 · Advanced Science · 被引 91)
• Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins (2023 · 癌症：英文版 · 被引 50)